Can You Spot the Signs? What You Need to Know About Leukemia Risks and Modern Care in the UAE

Treatment, diagnosis, and patient care have developed notably, with modern centers providing therapies that align with international standards. However, continued efforts are needed in research participation and public awareness, particularly regarding early detection.

Understanding Leukemia: What It Is and Who It Affects

Leukemia refers to a group of hematologic malignancies (blood cancers) originating in the bone marrow, where abnormal white blood cells multiply and impact the production of normal blood cells. Leukemia is categorized by both its progression speed (acute or chronic) and by the type of affected cell (lymphoblastic/lymphocytic or myeloid).

In the UAE, leukemia remains among the most frequently diagnosed cancers. According to 2021 data:

• Among males, it ranked as the third most common cancer after colorectal and prostate cancers.
• In children aged 0–14, leukemia is reported as the most common cancer.
• Overall cancer burden and mortality from leukemia are expected to increase by 2040, with projected cases in the UAE rising by nearly 230% compared to 2020, influenced by an aging population and shifts in lifestyle.

Main Types of Leukemia Seen in the UAE

Although detailed national data on leukemia subtypes is limited, available trends suggest similarities with global patterns:

• Acute Lymphoblastic Leukemia (ALL): Most frequently seen in children.
• Chronic Myeloid Leukemia (CML) and Acute Myeloid Leukemia (AML): More prevalent in adults.
• ALL and CML are central considerations in both pediatric and adult leukemia care.

Leukemia types can be rapid in progression (acute) or develop more slowly (chronic).

Recognizing Symptoms: When to Seek Help

Leukemia symptoms in both children and adults may resemble those of more common illnesses. Some possible symptoms include:

• Fever that persists
• Fatigue or weakness
• Frequent infections
• Easy bruising or bleeding (such as frequent nosebleeds or bleeding gums)
• Bone or joint pain
• Swollen lymph nodes (in areas like the neck, armpit, or groin)
• Pale skin (pallor)

If these symptoms are persistent or unexplained, seeking a medical evaluation is recommended. Prompt diagnosis can support treatment outcomes, particularly in children.

Diagnostic Process for Leukemia in the UAE (2025)

Diagnosis in the UAE is consistent with international protocols and is provided at all major cancer centers:

• Medical History & Physical Exam: Assessment of symptoms and risk factors.
• Laboratory Testing:
  • Complete Blood Count (CBC): Assesses abnormal white blood cell numbers and anemia.
  • Bone Marrow Biopsy/Aspiration: Used to confirm a leukemia diagnosis.
  • Cytogenetic and Molecular Tests: Assist in identifying leukemia subtypes and guiding treatment decisions (e.g., identifying the Philadelphia chromosome in CML).
• Advanced Imaging and Supportive Diagnostics: Employed to evaluate organ involvement.

Routine population screening for leukemia is not conducted in the UAE or globally, as no effective early-detection blood tests are currently available. Early diagnosis is supported by increased awareness among the public and healthcare providers.

Treatment Advances for Leukemia in the UAE

Core Treatment Modalities

Comprehensive leukemia care is accessible across the UAE at both pediatric and adult oncology centers:

• Chemotherapy: Primary treatment, using medications to target leukemia cells.
• Targeted Therapy: Medicines that focus on particular genetic changes or cellular pathways relevant to some leukemia cases (such as certain CML and ALL patients).
• Immunotherapy: Treatments that stimulate or enhance the body’s immune response to leukemia; options are expanding as research advances.
• Radiation Therapy: Sometimes used for localized disease or as part of preparation before stem cell transplantation; advanced technologies like cyberknife and image-guided radiation are available in select centers.
• Hematopoietic Stem Cell Transplant (HSCT/Bone Marrow Transplant):
  • May provide a chance for long-term remission, especially in high-risk or recurrent cases.
  • Can be performed with a patient’s own cells (autologous) or donated cells (allogeneic).
  • Since 2019, local adult and pediatric HSCT programs have been operational in the UAE, reducing the need for patients to seek care abroad.

Pediatric Leukemia Care

Care for children with leukemia in the UAE utilizes internationally recognized protocols, featuring:

• Intensive, risk-adapted chemotherapy.
• Access to bone marrow transplantation where indicated.
• Multidisciplinary supportive care, including medical, nutritional, and psychological support.

Supportive and Palliative Care

Advanced centers in the UAE offer supportive measures such as:

• Blood and platelet transfusions, antibiotics, and growth factors.
• Palliative care for symptom management and quality of life support as necessary.

Treatment Eligibility and Access

Eligibility for various treatments is based on leukemia type and stage, patient age, general health, and donor match availability for transplantation. Although specialized care is available in major hospitals, differences in access may exist between citizens and expatriates.

Cost Considerations

Cancer care for UAE citizens is generally covered under government healthcare plans. Expatriate patients typically require private insurance or may self-fund certain treatments. Charitable support and public initiatives are increasing, with the upcoming opening of the Hamdan Bin Rashid Cancer Hospital in Dubai expected to expand access further.

Leukemia Research and Clinical Trials in the UAE (2025)

• Participation in international clinical trials remains limited in the UAE due to early-stage research infrastructure and workforce.
• Efforts are ongoing to develop precision oncology research and expand clinical trial opportunities, but as of 2025, enrollment options in advanced leukemia trials are limited.
• Continued investment in local research, data collection, and collaboration with global research networks is encouraged.

Future Perspectives: Planning for Increased Burden

Leukemia incidence in the UAE is projected to increase by 2040. The health sector is working to expand infrastructure and training for healthcare professionals. Public awareness campaigns are highlighted as crucial given the reliance on recognizing symptoms early for diagnosis.

• Leukemia remains a leading cancer among children and males in the UAE.
• Symptoms can be similar to those of common illnesses; persistent or unexplained symptoms should be evaluated by a healthcare provider.
• Diagnosis and treatment protocols in the UAE are consistent with international standards, and advanced therapies including bone marrow transplantation are now available locally.
• No population-based screening for leukemia is in place; awareness and timely clinical assessment are important.
• Advanced pediatric care is offered, though opportunities for participation in clinical trials are limited for both children and adults.
• Costs and care access may vary for citizens and expatriates, but government and charitable initiatives are working to enhance care availability.
• Ongoing research, improved data collection, and enhanced public education are key priorities for addressing the anticipated increased cancer burden.

Sources

• Wiley: The current and future cancer burden in the GCC countries
• BMTClinic: Leukemia in Children: Causes, Symptoms, Diagnosis, and Treatment
• Springer: Cancer Care in the UAE

Disclaimer: All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. The information and materials contained in these pages and the terms, conditions and descriptions that appear, are subject to change without notice.